Regulation of Methylase METTL3 on Fat Deposition

Diabetes Metab Syndr Obes. 2021 Dec 20:14:4843-4852. doi: 10.2147/DMSO.S344472. eCollection 2021.

Abstract

N6-methyladenosine (m6A) is the most prevalent and abundant type of internal post-transcriptional RNA modification in eukaryotic cells. METTL3 is a methylation modifying enzyme, which can directly or indirectly affect biological processes, such as RNA degradation, translation and splicing. In addition, it was found that 67% of 3'-UTR regions containing m6A sites had at least one miRNA binding site, and the number of m6A at 3'-UTR sites was closely related to the binding sites of miRNA. With the improvement of human living standards, obesity has become a very serious and urgent problem. The essence of obesity is the accumulation of excess fat. Exploring the origin and development mechanisms of adipocyte from the perspective of fat deposition has always been a hotspot in the field of adipocyte research. The aim of the present review is to focus on METTL3 regulating fat deposition through mRNA/adipocyte differentiation axis and pri-miRNA/pre-miRNA/target genes/adipocyte differentiation and to provide a theoretical basis according to the currently available literature for further exploring this association. This review may provide new insights for obesity, fat deposition disease and molecular breeding.

Keywords: METTL3; adipocyte differentiation; intramuscular fat; m6A methylation; miRNA.

Publication types

  • Review

Grants and funding

This work was supported by Yangling Demonstration Area Industry University research and application collaborative innovation major project(1017cxy-15), Agricultural science and technology innovation and tackling key projects in Shaanxi Province (2016NY-108) and Integration and demonstration of rabbit breeding and factory breeding technology (2018ZDXM-NY-041).